z-logo
Premium
Externalities of National Pharmaceutical Policy when Markets are Integrated through Parallel Trade
Author(s) -
Birg Laura
Publication year - 2015
Publication title -
review of international economics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.513
H-Index - 58
eISSN - 1467-9396
pISSN - 0965-7576
DOI - 10.1111/roie.12177
Subject(s) - externality , competition (biology) , economics , international economics , price policy , international trade , competition policy , microeconomics , industrial organization , european union , ecology , agriculture , biology
This paper studies externalities of nationally determined cost‐sharing systems, in particular coinsurance rates, under pharmaceutical parallel trade in a two‐country model with a vertical distributor relationship. Parallel trade generates a price‐decreasing competition effect in the destination country of the parallel import and a price‐increasing double marginalization effect in the source country. An increase of the coinsurance rate in the destination country mitigates the double marginalization effect in the source country. An increase of the coinsurance rate in the source country reinforces the competition effect in the destination country. This may be a case for policy coordination in the E uropean U nion.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here